1995
Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): Initial validation and practical use. British Journal of Dermatology 1995; 132: 942-949.
1998
Ahmed I, Berth-Jones J, Friedmann P, Graham-Brown R, Cork M, Sowden J, Finlay A, Beard A, Sumner M, Harper JI. Short course versus continuous course therapy of cyclosporin in severe childhood atopic dermatitis. British Journal of Dermatology 1998; 139 (Suppl 51): 22.
Emerson RM, Lawson S, Williams HC. Do specialist eczema clinics benefit children with atopic dermatitis. British Journal of Dermatology 1998; 139 (Suppl 51): 46.
Fagan S, Frech F, Pattit KG, Bailey E, Kaniecki DJ, Arnold RJG, Fiveson D. MGB4 relationship between quality of life, disease severity, and physician visits in managed care patients with atopic dermatitis. Value in Health 1998; 1: 45-46.
Finlay AY, Coles EC, Lewis-Jones MS, Blackford S, Holt PJA, Howard A, Knight AG, Lanigan SW, Logan RA, Long CC, Marks R, Motley RJ, Roberts DLL, Statham BN, Wilkins J. Quality of life improves after seeing a dermatologist. British Journal of Dermatology 1998; 139 (Suppl 51): 15.
Finlay AY, Lewis-Jones MS, Sharp JL, Dykes PJ. Children’s Dermatology Life Quality Index: cartoon version validation. British Journal of Dermatology 1998; 139 (Suppl 51): 67.
Lewis-Jones MS, Finlay AY, Hill G, Dykes PJ. The impact of atopic dermatitis on children and their families: a community study. Annals de Dermatologie et Venerologie 1998; 125 (Suppl 1): S62.
2000
Ben-Gashir MA, Seed PT, Hay RJ. Are changes in family quality of life and disease severity related in children with atopic dermatitis (AD)? British Journal of Dermatology 2000; 143 (Suppl 57): 35.
Emerson RM, Batchelor J, Morris A Millard LG. How much disability is caused by vascular naevi in children? British Journal of Dermatology 2000; 143 (Suppl 57): 53.
Harper JI, Ahmed I, Barclay G et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. British Journal of Dermatology 2000; 142: 52-58.
Njoo M D, Bos J D, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42
(2 Pt 1): 245-53.
Shum RW, Lawton S, Williams HC, Docherty G, Jones J. The British Association of Dermatologists audit of atopic eczema management in secondary care. Phase 3: audit of service outcome. British Journal of Dermatology 2000; 142: 721-727.
2001
Ben-Gashir MA, Seed P T, Hay RJ. Quality of life and disease severity are correlated in children with atopic eczema. JEADV 2001; 15 (Suppl 2): 111.
Chaudhry S, Moss C, Gilmour E. Quality of life measurements in children with atopic eczema from different ethnic groups in Birmingham. Br J Dermatol 2001; 145 (Suppl 59): 45.
Drake L, Prendergast M, Maher R et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001; 44: S65-S72.
Eiser C, Morse R. Quality of life measures in chronic diseases of childhood. Health Technol Assess 2001; 5(4): pages 31, 35, 37, 43, 143.
Poyner TF, Sibley G, Chim DJ. The effects of a nurse-run clinic in primary care on the quality of life of children with atopic eczema. Br J Dermatol 2001; 145:
(Suppl 59): 22.
Titman P S, Barker C, Smith C H. The psychological impact of chronic eczema on children and families. Br J Dermatol 2001; 145 (Suppl 59): 128-129.
2002
Aziah M S, Rosnah T, Mardziah A, Norzila M Z. Childhood atopic dermatitis: a measurement of quality of life and family impact. Med J Malaysia 2002; 57:
329-39.
Chinn D J, Poyner T Sibley G. Randomised controlled trial of a single dermatology nurse consultant in primary care on the quality of life of children with atopic eczema. Br J Dermatol 2002; 146: 432-439.
Fivenson D, Arnold R J G, Kaniecki D J, Cohen J L, Frech F, Finlay A Y. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organisation. J Managed Care Pharmacy 2002; 8 (5): 333-342
Hanifin J, Allen R, De Prost Y, Luger T. Validation of the eczema area and severity index (EASI) for atopic dermatitis in 1,533 patients from the pimecrolimus 1% cream clinical programme. Ann Dermatol Venereol 2002; 129: 1S411.
Horn H M, Tidman M J. Quality of life in epidermolysis bullosa. Clin Exp Dermatol 2002; 27(8): 707-710.
Keibert G, Sorensen SV, Revicki D, Fagan SC, Doyle JJ, Cohen J, Fiveson D. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41: 151-8.
Taieb C, Nocera T, Verriere F, Martinsic M A, Bouissou P, Myon E. Impact of skin diseases on the quality of life of children and their parents. JEADV 2002; 16 (Suppl 1): 267.
Verboom P, Hakkaart-Van Roijen L. The cost effectiveness of pimecrolimus (SDZ ASM 981) topical cream 1% and corticosteriods in the treatment of atopic dermatitis. Ann Dermatol Venereol 2002; 129: 1S425.
Whalley D, McKenna S, Huels J, Van Assche D. Pimecrolimus (SDZ ASM 981) in the treatment of paediatric atopic eczema: Benefit to quality of life and health-related quality of life. Ann Dermatol Venereol 2002; 129: 1S426.
2003
Beattie P E & Lewis-Jones M S. Impairment of quality of life in children with skin disease: further validation studies of the Children’s Dermatology life quality Index © and the Children’s Life quality Index ©. Br J Dermatol 2003; 149 (Suppl 64): 77-78.
Charman C, Chambers C Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol 2003; 120 (6): 932-941.
Chuh A A. Quality of life in children with pityriasis rosea: a prospective case control study. Pediatric Dermatology 2003; 20 No 6: 474-478.
Chuh A A. Validation of a Cantonese version of the Children’s Dermatology Life Quality Index. Pediatric Dermatology 2003; 20 No 6: 479-481.
Fleckman P, Hamill G, Weinstock M A. The National Registry for Ichthyosis and Related disorders – health related quality of life and patient reported outcomes.
J Invest Dermatol 2003; 121(1): 0420.
Holme S A, Mann I, Sharpe J L, Dykes P J, Lewis-Jones M S, Finlay A Y. The Childrens’ Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003; 148: 285-290.
Nocera T, Veriere F, Myon E, Taieb C. Impact of hydrotherapy care on the quality of life of children. Quality of Life Research 2003; 12: 777.
Taieb C, Verriere F, Nocera T, Myon E. Impact of hydrotherapy care on the quality of life of children. JEADV 2003; 17 (Suppl 3): 336.
2004
Austin E, Phillips G, Lewis-Jones S. The prevalence of fusidic acid-resistant Staphylococcus aureus colonization in paediatric outpatients with atopic dermatitis. Br J Dermatol 2004; 151 (Suppl 68):74.
Ben-Gashir M A, Seed P T, Hay R J. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004; 150: 284-290.
Charman C R, Venn A J, Williams H C. The patient-orientated eczema measure – development and validation of anew tool for measuring atopic eczema severity from the patients’ perspective. Paed Dermatol 2004; 21 (3): 337. Arch Dermatol 2004; 140: 1513-1519.
Finlay A Y, Myon E, Martin N, Verriere F, Taieb C. Impact of thermal spa on children’s quality of life. JEADV 2004; 18 (Suppl 2) 310.
Grad O, Niren N, Sung J, Law A. Impact of atopic dermatitis treatment on quality of life: Results from findings in atopic children with eczema (face) study. J Am Acad Dermatol 2004; 50(3): P65.
Won C, Seo P, Park Y, Yang J, Lee K, Sung K, Park C, Kim D, Change H, Won Y Kim K. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea. J Dermatolog Treat 2004; 15(1): 30-34.
Woo P N, White M I. A family study of erythrokeratoderma variabilis. Br J Dermatol 2004; 151 (Suppl 68): 71.
2005
Agredano Y, Alster T S, Bryan H A, Weiss S C. Quality of life assessment of patients with port-wine stains receiving flashlamp-pulsed dye laser treatment. J Am Acad Dermatol 2005; 52(Suppl 1):
Baron S E, Layton A, Goulden V. A pilot study of hypnotherapy to treat adults and children with moderate to severe atopic dermatitis. Br J Dermatol 2005; 153 (Suppl 1): 37.
Blanchet-Bardon C, Corre J-M, Le C N. Health-related quality of life in ichthyosis patients and family members. J Am Acad Dermatol 2005; 52(Suppl 1): 110.
Charman C R, Venn A J, Williams H. Measuring atopic eczema severity visually: which variables are most important to patients? Arch Dermatol: 2005; 141: 1146-1151.
Holm E A, Esmann S, Jemec. Patient Education and morbidity in atopic eczema. Dermatol Nursing 2005; 17(1): 35-45.
Holme S A, Anstey A V, Badminton M N, Elder G H. UK prospective study on erythropoietic protoporphyria: quality of life assessment. Br J Dermatol 2005; 153
(Suppl 1): 41.
Weber M, Mazzotti N, Barzenski B, Silva T. Evaluation of the quality of life in patients with atopic dermatitis participating in support groups. J Am Acad Dermatol 2005; 52 (Suppl 1): 70.
2006
Baron S, Layton A, Goulden V. A Pilot study of hypnotherapy to treat adults and children with moderate to severe atopic dermatitis. J Am Acad Dermatol 2006; 54: AB2
Beattie P E, Lewis-Jones M S. A comparative study of impairment of quality of life in children with skin diseases and children with other chronic child diseases. Br J Dermatol 2006 155: 145-151.
Berth-Jones J, Arkwright PD, Marasovic D, Savani N, Aldridge CR, Leech SN, Morgan C, Clark SM, Ogilvie S, Chopra S, Harper JI, Smith CH, Rook GA, Friedmann PS. Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randmized, double-blind, placebo-controlled trial. Clin Exp Allergy 2006; 36: 1115-21.
Bryemo G, Rod G, Carlsen KH. Effect of climatic change in children with atopic eczema. Allergy 2006; 61: 1403-10.
Gordano-Labadie F, Cambazard F, Guillet G, Combemale P, Mengeaud V. Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis. J Dermatolog Treat. 2006; 17: 78-81.
Grillo M, Gassner L, Marshman G, Dunn S, Hudson P. Pediatric atopic eczema: the impact of an educational intervention. Pediatr Dermatol 2006; 23: 428-36.
Holm E A, Wulf H C, Stegmann H, Jemec G B E. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006; 54: 719-725.
Holme S A, Anstey A V, Finlay A Y, Elder G H, Badminton M N. Erythropoietic protoporphyria in the UK: clinical features and effect on qualify of life. Br J Dermatol 2006; 155: 574-581.
Hon K L E, Kam W Y C, Lam M C A, Leung T F, Ng P C. CDLQI, SCORAD and NESS: are they correlated? Quality of Life Research 2006; 15: 1551-1558.
Hon K L E, Lam M C A, Kam W Y C, Leung T F, Wong K Y, Lee K K C, Fok T F,
Ng P C. CDLQI, SCORAD and NESS: are they correlated? Br J Dermatol 2006 155: 106-119.
McKenna S P, Whalley D, de Prost Y, Staab D, Huels S J, Paul C F, van Assche D. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel®, SDZ ASM 981): impact on quality of life and health-related quality of life. JEADV 2006; 20: 248-254.
Shaw M, Goldsmith L, Morell D. The study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD). J Am Acad Dermatol 2006; 54: AB83
Sunderkotter C, Weiss J M, Bextermoller R. :Loffler ,. Schneider D. Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life. J Dtsch Dermatol Ges 2006; 4: 301-306.
Walker N, Lewis-Jones M S. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children’s Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI). J Eur Acad Dermatol Venereol 2006; 20: 45-50.
Weber M B, Soirefmann M, Mazzotti N G, Cestari T F. Improvement of pruritus, clinical manifestations and quality of life of patients with atopic dermatitis and their families after joining support groups. J Am Acad Dermatol 2006; 54: AB87.
2007
Bieber T, Vick K, Folster-Holst R, Belloni-Fortina A, Stadtler G, Worm M, Arcangeli F. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007; 62: 184-9.
Clayton T H, Clark S M, Britton J, Pavolv S, Radev S. A comparative study of the Children’s Dermatology Life Quality Index (CDLQI) in paediatric dermatology clinics in the UK and Bulgaria. JEADV 2007; 21: 1436-7.
Ganemo A, Svensson A, Lindberg M, Wahlgren C-F. Quality of life in Swedish children with eczema. Acta Derm Venereol 2007; 87:345-349.
Hon K L E, Leung T F, Ng P C, Lam M C A, Kam W Y C, Wong K Y, Lee K C K, Sung Y T, Cheng K F, Fok T F, Fung K P, Leung P C. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2007; 157: 357-363.
Hon KL, Lam MC, Wong KY, Leung TF, Ng PC. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P. Br J Dermatol 2007; 157: 922-5.
Mozaffari H, Pourpak Z, Pourseyed S, Farhoodi A, Aghamohammadi A, Movahadi M, Gharaghozloo M, Moin M. Quality of life in atopic dermatitis patients. J Microbiol Immunol Infect 2007; 40: 260-4.
2008
Chernyshov P V. Creation and cross-cultural adaptation of Ukrainian versions of questionnaires for assessment of quality of life of children with atopic dermatitis and their families. Lik Sprava 2008; 1-2: 124-8.
Hon KL, Ching GK, Wong KY, Leung TF, Leung AK. A pilot study to explore the usefulness of antibody array in childhood atopic dermatitis. J Natl Med Assoc 2008; 100: 500-4.
Hon KL, Leung TF, Wong KY, Chow CM, Chuh A, Ng PC. Does age or gender influence quality of life in children with atopic dermatitis? Clin Exp Dermatol 2008; 33: 705-9.
Hon KL, Wong KY, Leung TF, Chow CM. Ng PC. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. Am J Clin Dermatol 2008; 9: 45-50.
Katugampola R P, Badminton M N, Finlay A Y, Whatley S D, Woolf J. J-C Deybach, Puy H, Ged C, Verneuil H De, Hanneken S, Harms J H & Anstey A V. Congenital erythropoietic porphyria: a genotype/phenotype correlation and health-related quality of life study of 27 unrelated cases. Br J Dermatol 2008; 159 (Suppl 1): 7.
Peserico A, Städtler G, Sebastian M, Fernandez R S, Vick K, Bieber T. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 2008; 158: 801-807.
Pressley Z M, Pavlis M B, Veledar E, Badley B R, Spraker M K, Chen S C. Quality of life and burden of cutaneous disease in ectodermal dysplasia. J Investig Dermatol Online 2008; 128:S81; 484.
Rice Z P, Pavlis M B, Veledar E, Bradley B R, Spraker M K, Chen S C. Family impact of cutaneous disease in the ectodermal dysplasia. J Investig Dermatol 2008; 128: 2552.
Schmitt J, Meurer M, Schwanebeck U, Grählert X, Schäkel K. Treatment following an evidence-based algorithm versus individualised symptom-oriented treatment for atopic eczema. Dermatology 2008; 217: 299-308.
Shaw M, Morrell D S, Goldsmith L A. A Study of Targeted Enhanced Patient care for Pediatric Atopic Dermatitis (STEP PAD). Pediatric Dermatology 2008; 25: 19-24.
Taieb C, Martinsic M A, Nocera T, Bousetta S. Atopic dermatitis and thermal therapies: evaluation in children under 15. J Am Acad Dermatol 2008; P2314.
Weber MB, Fontes Neto Pde T, Prati C, Soirefman M, Mazzotti NG, Barzenski B, Cestari TF. Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. J Eur Acad Deramtol Venereol 2008; 22: 992-7.
Won C H, Park C W, Kim K H, Lan C C, Zhu X J, et al. Efficacy of tacrolimus and its effect on improvement of quality of life in patient with atopic dermatitis from Asia. JID Online 2008; 128:S69; 413.
2009
Arkachaisri T, Vilaiyuk S, Li S, O’Neil KM, Pope E, Higgins GC, Punaro M, Rabinovich EC, Rosenkranz M, Kietz DA, Rosen P, Spalding SJ, Hennon TR, Torok KS, Cassidy E, Medsger Ta Jr, Localized Scleroderma Clinical and Ultrasound Study Group. The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress towards development of localized scleroderma outcome measures. J Rheumatol 2009; 36: 2819-29.
Devereux C, McKenna K, Bingham A, Hoey S. S2. An audit to evaluate service outcome in children with atopic eczema attending a paediatric dermatology clinic. Ulster Med J 2009; 78: 200-201.
Huggins R H, Leithauser L A, Eide M J, Hexsel C L, Jacobsen G, Lim H W. Quality of life assessment and disease experience of patient members of a web-based hydroa vacciniforme support group. Photodermatology, Photoimmunology & Photomedicine 2009; 25: 209-215.
Huggins R H, Leithauser L A, Eide M J, Hexsel C L, Jacobsen G, Lim H W. Assessment of quality of life patient members of a web-based hydroa vacciniforme support group. J Investig Dermatol 2009; 129: S62.
Kubota Y, Yoneda K, Nakai K, Katsuura J, Moriue T, Matsuoka Y, Miyamoto I. Ohya Y. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study. J Am Acad Dermatol 2009; 60(2): 212-217.
Orzechowski NM, Davis DM, Mason TG 3rd, Crowson CS, Reed AM. Health-related quality of life in children and adolescents with juvenile localised scleroderma. Rheumatology (Oxford) 2009; 48: 670-2.
Schwatrz R, Sepulveda JE, Quintana T. Possible role of psychological and environmental factors in the genesis of childhood vitiligo. Rev Med Chil 2009; 137: 53-62.
Witt CM, Brinkhaus B, Pach D, Reinhold T, Wruck K, Roll S, Jackel T, Staab D, Wegscheider K, Willich SN. Homeopathic versus conventional therapy for atopic eczema in children: medical and economic results. Dermatology 2009; 219: 329-40.
Wolkenstein P, Rodriguez D, Terkal S, Gravier H, Buret V, Algans N, Simeoni MC, Bastuji-Garin S. Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases. Br J Dermatol 2009; 160: 844-8.
2010
Arkachaisri T, Vilaiyuk S, Torok KS, Medsger TA Jr. Development and initial validation of the localised scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford) 2010; 49: 373-81.
de Jager ME, van de Kerkhof PC, de Jong EM, Seyger MM. A cross-sectional study using the Children’s Dermatology Life Quality Index (CDLQI) in childhood psoriasis: the negative effect on the quality of life and moderate correlation of CDLQI and severity scores. Br J Dermatol 2010 Aug (epub).
Fleischer AB Jr, Boguniewicz M. An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature. J Drugs Dermatol 2010; 9: 488-98.
Hon KL, Chan IH, Chow CM, Wang SS, Lam CW, Ng PC, Leung TF. Specific IgE of common foods in Chinese children with eczema. Pediatr Allergy Immunol 2010 Jul (Epub)
Hon KL, Ching GK, Leung TF, Choi CY, Lee KK, Ng PC. Estimating emollient usage in patients with eczema. Clin Exp Dermatol 2010; 35: 22-6.
Hon KL, Wang SS, Hung EC, Lam HS, Lui HH, Chow CM, Ching GK, Fok TF, Ng PC, Leung TF. Serum levels of heavy metals in childhood eczema and skin diseases: friends or foes. Pediatr Allergy Immunol 2010; 21: 831-6.
Langley RG, Paller AS, Hebert AA, Creamer K, Weng HH, Jahreis A, Globe D, Patel V, Orlow SJ. Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial. J Am Acad Dermatol 2010 Jul (Epub).
Paulden M, Rodgers M, Griffin S, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M. Alitretinoin for the treatment of severe chronic hand eczema. Health Technol Assess 2010; 14 (Suppl 1): 39-46.
Pavlis MB, Rice ZP, Veledar E, Bradley BR, Spraker MK, Chen SC. Quality of life of cutaneous disease in the ectodermal dysplasias. Pediatr Dermatol 2010; 27: 260-5.
Ramirez-Anaya M, Macias ME, Velazquez-Gonzalez E. Validation of a Mexican Spanish version of the Children’s Dermatology Life Quality Index. Pediatr Dermatol 2010; 27: 143-7.
Schuttelaar ML, Vermeulen KM, Drukker N, Coenraads PJ. A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist. Br J Dermatol 2010; 162: 162-70.